Increasing cost pressure

The pharmaceutical industry has grown over the years, and this has made the case for the ever-growing logistics challenges. The high level of competition from generics and the growing cost sensitivity of healthcare organizations have led to an increase in cost pressure on the market. New channels such as internet pharmacies or patient-centric business models are re-shaping the industry and will continue to do so in the near future.

Increasing needs for control

Serialization as well as track & trace are high on the management agenda – due to the shift of growth to the Pharmerging 17, but also due to counterfeiting especially in those areas. This raises the need to exercise more control in logistics and the overall supply chain.

New logistics requirements

New pharmaceutical products come with increasing requirements, both from a regulatory perspective (i.e. GDP) and a logistics characteristics perspective (i.e. temperature-controlled distribution). In connection with patient-centric business models, these new logistics requirements present challenges and opportunities at the same time.

In defining their competitive position in the current market environment, pharmaceutical companies increase the degree of outsourcing and the usage of collaboration operation models with logistics service providers. This enables them to offer flexible approaches to manage the VUCA environment.

How CAMELOT helps

CAMELOT supports companies from the life sciences and pharmaceutical industry in tackling these challenges and optimizing their logistics networks using an integrated approach – from logistics strategy to implementation.

With increased cost pressure and trend to more personalized medicine the significance of pharma logistics has increased in the last years. Life sciences companies are looking for alternative distribution models and assessing what value and services logistics can add to the patient experience.
Andreas Gmür, Partner Logistics